...
首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >In vitro-in vivo extrapolation: estimation of human serum concentrations of chemicals equivalent to cytotoxic concentrations in vitro.
【24h】

In vitro-in vivo extrapolation: estimation of human serum concentrations of chemicals equivalent to cytotoxic concentrations in vitro.

机译:体外-体内外推法:估算相当于血清中细胞毒性浓度的化学药品的人血清浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study an extrapolation model for estimating serum concentrations of chemicals equivalent to in vitro effective concentrations is developed and applied to median cytotoxic concentrations (EC(50)) determined in vitro. Nominal concentrations of a chemical in serum and in vitro are regarded as equivalent, if they result in the same aqueous concentration of the unbound form. The algorithm used is based on equilibrium distribution and requires albumin binding data, the octanol-water partition coefficient (K(ow)), and the albumin concentrations and lipid volume fractions in vitro and in serum. The chemicals studied cover wide ranges of cytotoxic potency (EC(50): 2.5-530,000 microM) and lipophilicity (logK(ow): -5 to 7). Their albumin binding characteristics have been determined by means of an in vitro cytotoxicity test as described previously. The equivalent serum concentrations of 19 of the 33 compounds investigated, having high protein binding and/or lipophilicity, were substantially higher than the EC(50)-values, by factors of 2.5-58. Prominent deviations between the equivalent nominal concentrations in serum and in vitro were largely restricted to chemicals with higher cytotoxic potency (EC(50)< or =1000 microM). The results suggest that estimates of equivalent serum concentrations based on in vitro data are robust for chemicals with low lipophilicity (logK(ow)< or =2) and low potency (EC(50)>1000 microM). With more potent chemicals or those with higher lipophilicity partitioning into lipids and/or binding to serum proteins have to be taken into account when estimating in vivo serum concentrations equivalent to in vitro effective concentrations.
机译:在本研究中,外推模型用于估算等效于体外有效浓度的化学药品的血清浓度,并将其应用于体外确定的中值细胞毒性浓度(EC(50))。如果血清和体外化学品的标称浓度导致未结合形式的水溶液浓度相同,则认为它们是等效的。使用的算法基于平衡分布,并且需要白蛋白结合数据,辛醇-水分配系数(K(ow))以及体外和血清中白蛋白浓度和脂质体积分数。研究的化学物质涵盖了广泛的细胞毒性(EC(50):2.5-530,000 microM)和亲脂性(logK(ow):-5至7)。如前所述,已经通过体外细胞毒性试验确定了它们的白蛋白结合特性。具有33种高蛋白结合和/或亲脂性的33种化合物中,有19种的等效血清浓度比EC(50)值高2.5-58倍。血清和体外等效标称浓度之间的显着差异主要限于具有较高细胞毒性潜能(EC(50)<或= 1000 microM)的化学药品。结果表明,根据体外数据估算的等效血清浓度对于低亲脂性(logK(ow)<或= 2)和低效价(EC(50)> 1000 microM)的化学药品是可靠的。在估算与体外有效浓度相当的体内血清浓度时,必须考虑使用更有效的化学药品或具有更高亲脂性的化学药品分配到脂质中和/或与血清蛋白结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号